CAN1012
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CAN1012, covering 2024-10-31 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: CAN1012 in Pre-Malignant DCIS and LCIS [Phase 1]